Review article · 2025 · Open access

The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau

Jean‐Philippe Courade, Henrik Zetterberg, Günter U. Höglinger, Ilse Dewachter

Cell, 188(26), 7337–7354 · Published 1 December 2025 · DOI 10.1016/j.cell.2025.11.033

Open full textCite this paper

In brief

“The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau” is a 2025 review article by Jean‐Philippe Courade and 3 co-authors, published in Cell. OpenAlex counts 66 citations as of 17 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Cell.

Citations
66
Most cited in
2026 (66)
Field-weighted impact
5.14
References
154
Authors
4

Abstract

A marked evolution in Alzheimer's disease (AD) therapy research is ongoing. In this perspective, we highlight emerging outcomes of tau-targeting approaches with disease-modifying potential evidenced by PET-based slowing of tau accumulation and early signs of cognitive benefit. We outline how decades of iterative amyloid β (Aβ)-trial refinement leading to the recent successes of approved anti-Aβ therapies have set the stage for accelerated optimization of next-generation trials. We summarize key learnings from first-generation tau immunotherapies and how these paved the way for early achievements in tau trials, while many challenges remain. Finally, we discuss the back-translation of clinical outcomes into fundamental insights on human tau pathobiology, and we outline challenges and future directions for AD therapy development including combination therapy and targets beyond Aβ/tau. Together, this provides a framework for next-generation AD and tau-therapy development toward increasingly efficient disease-halting interventions.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Courade, J., Zetterberg, H., Höglinger, G. U., & Dewachter, I. (2025). The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau. Cell, 188(26), 7337–7354. https://doi.org/10.1016/j.cell.2025.11.033

MLA 9

Courade, Jean‐Philippe, et al. “The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau.” Cell, vol. 188, no. 26, 2025, pp. 7337–7354. https://doi.org/10.1016/j.cell.2025.11.033.

Chicago

Courade, Jean‐Philippe, Henrik Zetterberg, Günter U. Höglinger, and Ilse Dewachter. 2025. “The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau.” Cell 188 (26): 7337–7354. https://doi.org/10.1016/j.cell.2025.11.033.

Harvard

Courade, J. et al. (2025) ‘The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau’, Cell, 188(26), pp. 7337–7354. doi:10.1016/j.cell.2025.11.033.

IEEE

J. Courade, H. Zetterberg, G. U. Höglinger, and I. Dewachter, “The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau,” Cell, vol. 188, no. 26, pp. 7337–7354, 2025, doi: 10.1016/j.cell.2025.11.033.

BibTeX

@article{courade2025evolving,
  title     = {{The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau}},
  author    = {Courade, Jean‐Philippe and Zetterberg, Henrik and Höglinger, Günter U. and Dewachter, Ilse},
  journal   = {Cell},
  year      = {2025},
  volume    = {188},
  number    = {26},
  pages     = {7337--7354},
  doi       = {10.1016/j.cell.2025.11.033},
  url       = {https://doi.org/10.1016/j.cell.2025.11.033}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • Alzheimer's disease
  • amyloid-beta
  • anti-amyloid therapy
  • tau PET imaging
  • tau accumulation
  • tau immunotherapy
  • disease-modifying therapy
  • combination therapy

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Courade, J., Zetterberg, H., Höglinger, G. U., & Dewachter, I. (2025). The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau. Cell, 188(26), 7337–7354. https://doi.org/10.1016/j.cell.2025.11.033

How many times has this paper been cited?

66 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cell: sign in and open the full text from this page.

Who wrote this paper?

Jean‐Philippe Courade, Henrik Zetterberg, Günter U. Höglinger, Ilse Dewachter.

What is the DOI of this paper?

10.1016/j.cell.2025.11.033, permanently at https://doi.org/10.1016/j.cell.2025.11.033. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.